GMAB
Genmab·NASDAQ
--
--(--)
--
--(--)
3.74 / 10
Netural
Technical assessment is neutral (3.74/10). MACD Death Cross scores 5.91, offering modest upside, while MACD Golden Cross is bearish (1) and Marubozu White is neutral (4.3). Signals are sparse, indicating volatility and no clear short‑term direction.
Analysis Checks(1/3)
MACD Death Cross
Score5.91/10
Win Rate60.00%
Hist. Signals10
Avg Return0.16%
Score5.91/10
Win Rate60.00%
Hist. Signals10
Avg Return0.16%
Marubozu White
Score4.3/10
Win Rate53.85%
Hist. Signals13
Avg Return0.32%
Score4.3/10
Win Rate53.85%
Hist. Signals13
Avg Return0.32%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-0.48%
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-0.48%
MACD Death Cross
Score5.91/10
Win Rate60.00%
Hist. Signals10
Avg Return0.16%
Score5.91/10
Win Rate60.00%
Hist. Signals10
Avg Return0.16%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-0.48%
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-0.48%
Marubozu White
Score4.3/10
Win Rate53.85%
Hist. Signals13
Avg Return0.32%
Score4.3/10
Win Rate53.85%
Hist. Signals13
Avg Return0.32%
Technical Analysis of GMAB?
- GMAB presents a Netural setup with a Technical Score of 3.74/10. Key technical indicators highlight an RSI of 35.90 and a MACD of 0.23, with the trend anchored by the 50-Day SMA at 29.31. Traders should monitor key support at 25.58 and resistance at 26.26.
